Concomitant administration of cholestyramine influences the absorption of troglitazone

British Journal of Clinical Pharmacology

Volumn 45, Issue 1, 1998, Pages 37-40

  Young, M A ^a   Lettis, S ^a   Eastmond, R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cholestyramine; Interaction; Pharmacokinetics; Troglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTILIPEMIC AGENT; COLESTYRAMINE; ORAL ANTIDIABETIC AGENT; TROGLITAZONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BILE ACID SYNTHESIS; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOG; DRUG ABSORPTION; DRUG MIXTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ABSORPTION; ADMINISTRATION, ORAL; ADULT; ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTYRAMINE; CHROMANS; CROSS-OVER STUDIES; DOGS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031951044     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00645.x     Document Type: Article

References (9)

1. Young MA, Lettis S, Eastmond R. Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after food. Br J Clin Pharmacol 1998; 45: 31-35.
2. Dollery C. Cholestyramine. Ed. Therapeutic Drugs Vol 1. Churchill Livingstone 1991; pp. C225-228.
3. Questran. Questran Light. ABPI Data Sheet Compendium 1995/96; DataPharm Publications, London. 1995; pp. 316-317.
4. Koch GG. The use of nonparametric methods in statistical analysis of the two period change-over design. Biometrics 1972; 28: 577-588.
5. Jones B, Kenward MG. Design and analysis of cross-over trials, 1st Edition, Chapman and Hall, London, 1989; pp. 58-89.
6. Pabst G, Jaegar H. Review of methods and criteria for the evaluation of bioequivalence studies. Eur J Clin Pharmacol 1990; 38: 5-10.
7. Lawlor DP, Hyers TM, Tepper D, Schweitzer P. Extreme prolongation of the prothrombin time in a patient receiving warfarin and cholestyramine. Cardiovasc Rev Rep 1993; 14: 72-74.
8. Harmon SM, Seifert CF. Levothyroxine-cholestyramine interaction reemphasized. Ann Intern Med 1991; 115: 658-659.
9. Koivisto KT, Neuvonen PJ. The effect of cholestyramine and activated charcoal on glipizide absorption. Br J Clin Pharmacol 1990; 30: 733-736.